Vibriosis, more accurately termed bovine genital campylobacteriosis, is a venereal disease of cattle caused by the bacterium Campylobacter fetus subspecies venerealis. This sexually transmitted infection affects the reproductive tract of both bulls and cows, resulting in infertility, early embryonic death, and occasionally abortion. The disease represents one of the most economically significant venereal diseases in cattle, particularly affecting beef operations that rely on natural service breeding rather than artificial insemination.
The prevalence of campylobacteriosis varies by region and management system but remains a significant concern in cattle operations worldwide. The disease occurs wherever cattle are raised using natural breeding methods and has been identified on every continent where cattle production exists. In endemic regions, infection rates within affected herds can be substantial, though widespread vaccination programs have reduced prevalence in many areas compared to historical levels. Beef cattle operations using range breeding systems face particular risk due to the challenges of monitoring reproductive performance under extensive management conditions.
The economic impact of vibriosis manifests through multiple pathways affecting herd productivity. Infected herds experience reduced conception rates, increased numbers of open cows at the end of the breeding season, extended calving intervals, and later-born calves with consequently lighter weaning weights. The cumulative effect of these losses can substantially reduce annual calf crop value. Additional costs include testing programs, vaccination purchases, treatment expenses for bulls, and potential bull replacement when treatment fails or is not economically justified.
Unlike trichomoniasis, another major venereal disease of cattle, campylobacteriosis responds to treatment and vaccination, making it a more manageable condition when properly addressed. Bulls can often be successfully treated with antibiotic therapy, and cows typically develop immunity following infection, gaining resistance to future disease. Effective vaccines are commercially available and provide good protection when incorporated into herd health programs. This treatability makes vibriosis a condition where appropriate intervention can successfully restore herd fertility when infection is identified and addressed promptly.
